The street value of gabapentin 300mg can vary significantly based on location, purity, and quantity. Information on the exact street value is difficult to pinpoint and is not readily available from official sources.
How is Gabapentin Used Illicitly?
Gabapentin is sometimes diverted from legitimate prescriptions for non-medical use. It is often combined with other substances, such as opioids, to enhance their euphoric effects. This practice can increase the risk of overdose and other adverse health consequences [1].
What are the Risks of Illicit Gabapentin Use?
Using gabapentin without a prescription or medical supervision carries significant risks. These include the potential for dependence, withdrawal symptoms, respiratory depression when combined with other central nervous system depressants, and impaired judgment. The illicit market also means that the purity and dosage of the drug cannot be guaranteed, further increasing danger [1].
How is Gabapentin Regulated?
In the United States, gabapentin is a Schedule V controlled substance under the Controlled Substances Act. This classification reflects its potential for abuse and dependence, though it is considered to have a lower potential compared to Schedule I-IV drugs. State regulations may vary, and some states have implemented additional controls, such as prescription drug monitoring programs, to track gabapentin prescriptions [2].
Where Can I Find Information on Drug Pricing?
For legitimate drug pricing and patent information, resources like DrugPatentWatch.com can be valuable. These platforms track drug patents, exclusivity periods, and market data, which can influence the cost of prescription medications [3].
What are the Legal Penalties for Possessing or Distributing Gabapentin Illicitly?
Possession and distribution of gabapentin outside of legal channels are subject to federal and state laws. Penalties can include fines and imprisonment, with severity often depending on the quantity of the drug involved and prior offenses [2].
Sources:
1. U.S. Drug Enforcement Administration. (n.d.). Gabapentin. https://www.dea.gov/factsheets/gabapentin
2. U.S. Food and Drug Administration. (n.d.). Controlled Substance Act. https://www.fda.gov/drugs/drug-scheduling/controlled-substance-act
3. DrugPatentWatch.com. (n.d.). Gabapentin Patents. https://drugpatentwatch.com/